Repotrectinib effective in ROS1-fusion-positive NSCLC
Crossref DOI link: https://doi.org/10.1038/s41571-024-00864-4
Published Online: 2024-01-26
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2024-01-26
Version of Record valid from 2024-01-26
Article History
First Online: 26 January 2024